Customized Services for Animal Model of Hymenolepis diminuta Infection

Customized Services for Animal Model of Hymenolepis diminuta Infection

Hymenolepis diminuta Animal Model Customization Service

Hymenolepis diminuta, also known as the long cestode, is a human-animal parasite. It is mainly parasitic in rodents, but occasionally also in dogs, monkeys and humans. Its intermediate hosts are mainly beetles, fleas, cockroaches and more than 20 other arthropods, while rat fleas and flour beetles are the main natural intermediate hosts. Final hosts such as rats and humans are infected by ingesting intermediate hosts with cysticercus larvae. Most infected individuals have no obvious clinical symptoms or only mild neurological and gastrointestinal symptoms such as headache, insomnia, teeth grinding, nausea, abdominal distension and abdominal pain. Severely infected individuals may develop vertigo, anemia, mental dementia or cachexia. Its gravid or eggs are excreted with the feces of the final host, swallowed by the intermediate host and then hatch in its digestive tract as hexacercariae, which then pass through the intestinal wall into the blood.

Ace Therapeutics specializes in parasitology and has established a technical platform for the development of animal models of parasitic diseases, aiming to provide development and customization services for various animal models of parasitic diseases for clients worldwide. We provide animal model development services for Hymenolepis diminuta. This provides a good model for the morphology, life history and especially the molecular biology of Hymenolepis diminuta.

Customization Service Options for Animal Models of Hymenolepis diminuta Infection

We can establish an Hymenolepis diminuta model for you in rats, it can be used for scientific research and drug research of Hymenolepis diminuta. If you want to know more, you are welcome to consult us.

  • Rat model of Hymenolepis diminuta

Model animals: rat (and Tribolium castaneum)

Source of parasite: eggs from fresh feces of positive Hymenolepis diminuta rats.

Reproduction method: the eggs of Hymenolepis diminuta were artificially fed/infected with newly reproduced Tribolium castaneum; after 14 d Tribolium castaneum was dissected and live cysticercoid were collected and placed in saline. They were then injected into the stomach of healthy rats.

Model characteristics: on the 18th day after infection, rats can be positive for fecal examination of eggs or gravid proglottids.

Application: the animal model replicated by this method can be used to study the interaction between Hymenolepis diminuta and humans, the diagnosis of Hymenolepis diminuta infection and its prevention and treatment.

Service Details

Delivery content: experiment report and Hymenolepis diminuta animal model
Test fee: please get it through online inquiry.

Service Flow

  1. Communicate your requirements with us via online inquiry or telephone.
  2. Communicate the requirements (Number, degree of infection, etc.) of Hymenolepis diminuta animal model customization, sign the contract and pay the deposit.
  3. Fill out the sample order and send the samples (optional).
  4. Establish Hymenolepis diminuta animal model and prepare experiment report.
  5. Delivery of report and animal model.

Our Advantages

  • We offer rat models of Hymenolepis diminuta that can be used for scientific research and drug research of Hymenolepis diminuta. If you have special needs, please consult us for customization.
  • Our professional technicians have extensive experience in parasite animal model development.
  • Advanced technology platform, scientific management system, and standard R&D procedures.
  • In addition to Hymenolepis diminuta animal model customization service, we also provide Hymenolepis diminuta identification services (Mainly fecal testing).
  • The project cycle time is short and the price is competitive.
All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.

Contact Info
Copyright © Ace Therapeutics. All Rights Reserved.